Theodore Search

Director at OS Therapies

Capital raised by OS Therapies

$11.6M+$1.6M latest round

4 Form D filings · first filed Jun 2025 · Grasonville, MD

CURRENT ROLE: Director
SECTOR: Biotech
COMPANY FILINGS: 4
TEAM ON FILE: 2
FOUNDED: —
30D INTEREST: —

Career

1 company on file

OS TherapiesBiotech · Grasonville, MDsince Jun 2025

Director

Listed on OS Therapies's Form D filings

Company filings

via EDGAR · Form D for OS Therapies4

DateCompanyFormAmountRole on filing

Jun 30, 2026OS TherapiesForm D+$1.6M—

Form DJun 30, 2026 · OS Therapies+$1.6Mnot a signer

Mar 4, 2026OS TherapiesForm D+$2.0M—

Form DMar 4, 2026 · OS Therapies+$2.0Mnot a signer

Sep 2, 2025OS TherapiesForm D+$3.8M—

Form DSep 2, 2025 · OS Therapies+$3.8Mnot a signer

Jun 23, 2025OS TherapiesForm D+$4.2M—

Form DJun 23, 2025 · OS Therapies+$4.2Mnot a signer

Overview

Last filing Jun 30, 2026

Theodore Search is on file as Director at OS Therapies in Grasonville, MD. OS Therapies has 4 Form D filings on record, $11.6M raised in total.

Teammates

OS Therapies · 1

Christopher P. AcevedoChief Financial OfficerSigner

Products

OS Therapies · 1

Lead Immunotherapy CandidateClinical-Stage Immunotherapy

The company's flagship product is an immunotherapy drug currently in human clinical trials. It is engineered to activate the body's immune system to recognize and eliminate cancer cells that express the HER2 protein, with an initial indication for osteosarcoma and potential application across other solid tumors.